Trends in the chemical industry
State of the art with Bross & Partner
Production and logistics in the pharmaceutical and chemical industry
Modular, networked plants, automated process controls, predictive maintenance or asset performance management solutions are just a few examples of the trends in the chemical industry. Customized products and ever shorter delivery times require a flexible and agile approach. The pharmaceutical industry is undergoing a transformation caused by several external factors. The large companies that have traditionally relied on blockbuster drugs sold in this volume are experiencing unprecedented upheaval. With patents expiring and a large number of new entrants creating pricing pressure, there is a shift in patient expectations. This general trend in the pharmaceutical industry is shifting some focus from cure to prevention. Bross & Partner supports companies in this sector, for example, in improving operational efficiency, redesigning or increasing plant availability. Bross & Partner’s customers include pharmaceutical and chemical industries as well as plant manufacturers in the process industry and industrial service providers.
Current trends in the chemical and pharmaceutical industry
Prevention better than cure
Genetic engineering and similar technological trends in the chemical and pharmaceutical industries are enabling patients to receive preventive medical care. The shift is slow, but there are significant expectations. As a result, many of these diseases that needed drugs no longer exist. The deterrents look ominous, but they also create a world of opportunity for healthcare and life sciences companies. There will be growth through innovation and the use of new technologies such as cloud, Big Data, artificial intelligence and blockchain.
Regulatory compliance in the emerging online environment is a major challenge for healthcare and life sciences organizations. Along with application modernization, these companies will seek to automate compliance. Quality checks will ensure that at every stage of drug development, the process is automated to avoid delays and discrepancies.
Artificial intelligence forms one of the most dominant trends in the pharmaceutical industry. Companies in pharmaceutical and chemical industries such as healthcare and life sciences are facing the new wave of technological innovations driven by advances in AI and machine learning to develop cures faster and provide effective care. Today, use is limited due to fragmented data and limited availability of data scientists.